Cell Reports (May 2023)

Dissecting the effects of GTPase and kinase domain mutations on LRRK2 endosomal localization and activity

  • Capria Rinaldi,
  • Christopher S. Waters,
  • Zizheng Li,
  • Karl Kumbier,
  • Lee Rao,
  • R. Jeremy Nichols,
  • Matthew P. Jacobson,
  • Lani F. Wu,
  • Steven J. Altschuler

Journal volume & issue
Vol. 42, no. 5
p. 112447

Abstract

Read online

Summary: Parkinson’s disease-causing leucine-rich repeat kinase 2 (LRRK2) mutations lead to varying degrees of Rab GTPase hyperphosphorylation. Puzzlingly, LRRK2 GTPase-inactivating mutations—which do not affect intrinsic kinase activity—lead to higher levels of cellular Rab phosphorylation than kinase-activating mutations. Here, we investigate whether mutation-dependent differences in LRRK2 cellular localization could explain this discrepancy. We discover that blocking endosomal maturation leads to the rapid formation of mutant LRRK2+ endosomes on which LRRK2 phosphorylates substrate Rabs. LRRK2+ endosomes are maintained through positive feedback, which mutually reinforces membrane localization of LRRK2 and phosphorylated Rab substrates. Furthermore, across a panel of mutants, cells expressing GTPase-inactivating mutants form strikingly more LRRK2+ endosomes than cells expressing kinase-activating mutants, resulting in higher total cellular levels of phosphorylated Rabs. Our study suggests that the increased probability that LRRK2 GTPase-inactivating mutants are retained on intracellular membranes compared to kinase-activating mutants leads to higher substrate phosphorylation.

Keywords